Alder Biopharmaceuticals prepares to ramp up hiring effort
Following a $40 million venture round in January, Seattle-based Alder Biopharmaceuticals has plans to ramp up its antibody work and will hire a number of new researchers. In a move to boost its staff from 34 to about 50, the biotech is searching for workers skilled at antibody manufacturing and clinical development. That's all good news for the Seattle area, where the biotech scene has been the center of more downsizing than upsizing in recent years.
- read the report in the Seattle Times
Related Articles:
Alder lands $40M in third round
Alder pockets $16M in VC
Be the first to comment
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets